Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous Abatacept for Prevention of aGVHD After Haplo-identical HCT
NCT04686929Phase 2Completed
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in Acute Graft-Versus-Host Disease (aGvHD), sponsored by First Affiliated Hospital of Soochow University. Started Jun 2021; status: completed.
02
Drugs
abatacept
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT04686929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04686929.